This company has been marked as potentially delisted and may not be actively trading. GTX (GTXI) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsHeadlinesTrendsBuy This Stock GTXI vs. FBIO, DOMH, AGEN, BOLT, SABS, CRIS, MTEM, AMGN, GILD, and VRTXShould you be buying GTX stock or one of its competitors? The main competitors of GTX include Fortress Biotech (FBIO), Dominari (DOMH), Agenus (AGEN), Bolt Biotherapeutics (BOLT), SAB Biotherapeutics (SABS), Curis (CRIS), Molecular Templates (MTEM), Amgen (AMGN), Gilead Sciences (GILD), and Vertex Pharmaceuticals (VRTX). These companies are all part of the "biotechnology" industry. GTX vs. Fortress Biotech Dominari Agenus Bolt Biotherapeutics SAB Biotherapeutics Curis Molecular Templates Amgen Gilead Sciences Vertex Pharmaceuticals GTX (NASDAQ:GTXI) and Fortress Biotech (NASDAQ:FBIO) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their risk, analyst recommendations, community ranking, earnings, valuation, profitability, dividends, media sentiment and institutional ownership. Which has more volatility & risk, GTXI or FBIO? GTX has a beta of 2.22, suggesting that its stock price is 122% more volatile than the S&P 500. Comparatively, Fortress Biotech has a beta of 1.82, suggesting that its stock price is 82% more volatile than the S&P 500. Does the MarketBeat Community believe in GTXI or FBIO? Fortress Biotech received 13 more outperform votes than GTX when rated by MarketBeat users. However, 73.60% of users gave GTX an outperform vote while only 63.69% of users gave Fortress Biotech an outperform vote. CompanyUnderperformOutperformGTXOutperform Votes31573.60% Underperform Votes11326.40% Fortress BiotechOutperform Votes32863.69% Underperform Votes18736.31% Do analysts recommend GTXI or FBIO? Fortress Biotech has a consensus price target of $21.00, indicating a potential upside of 1,180.49%. Given Fortress Biotech's stronger consensus rating and higher possible upside, analysts plainly believe Fortress Biotech is more favorable than GTX.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score GTX 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Fortress Biotech 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has better earnings and valuation, GTXI or FBIO? GTX has higher earnings, but lower revenue than Fortress Biotech. Fortress Biotech is trading at a lower price-to-earnings ratio than GTX, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioGTXN/AN/A-$38.42M-$1.65-0.32Fortress Biotech$57.68M0.84-$60.64M-$2.78-0.59 Is GTXI or FBIO more profitable? GTX has a net margin of 0.00% compared to Fortress Biotech's net margin of -84.53%. Fortress Biotech's return on equity of 0.00% beat GTX's return on equity.Company Net Margins Return on Equity Return on Assets GTXN/A -104.19% -86.42% Fortress Biotech -84.53%N/A -34.93% Does the media prefer GTXI or FBIO? In the previous week, GTX had 1 more articles in the media than Fortress Biotech. MarketBeat recorded 2 mentions for GTX and 1 mentions for Fortress Biotech. Fortress Biotech's average media sentiment score of 1.87 beat GTX's score of 0.00 indicating that Fortress Biotech is being referred to more favorably in the news media. Company Overall Sentiment GTX Neutral Fortress Biotech Very Positive Do insiders & institutionals believe in GTXI or FBIO? 9.5% of GTX shares are owned by institutional investors. Comparatively, 96.5% of Fortress Biotech shares are owned by institutional investors. 40.9% of GTX shares are owned by insiders. Comparatively, 33.4% of Fortress Biotech shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term. SummaryFortress Biotech beats GTX on 9 of the 17 factors compared between the two stocks. Get GTX News Delivered to You Automatically Sign up to receive the latest news and ratings for GTXI and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart GTXI vs. The Competition Export to ExcelMetricGTXPharmaceutical Preparations IndustryMedical SectorNASDAQ ExchangeMarket Cap$12.67M$6.71B$5.47B$7.82BDividend YieldN/A3.17%5.43%4.27%P/E Ratio-0.327.2322.3918.44Price / SalesN/A239.71391.43101.46Price / CashN/A65.8538.1834.62Price / Book0.486.306.684.19Net Income-$38.42M$143.17M$3.22B$248.05M GTX Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)GTXIGTXN/A$0.53flatN/AN/A$12.67MN/A-0.3221FBIOFortress Biotech2.3475 of 5 stars$1.52-3.2%$21.00+1,281.6%-4.7%$44.89M$57.68M-0.50170Gap UpDOMHDominari1.021 of 5 stars$3.95+1.0%N/A+77.4%$43.11M$12.59M-1.024Positive NewsAGENAgenus3.4277 of 5 stars$1.69-5.1%$8.75+417.8%-76.9%$42.77M$103.46M-0.15440Analyst RevisionNews CoverageBOLTBolt Biotherapeutics3.0162 of 5 stars$0.35-6.8%$1.13+226.1%-64.9%$13.23M$7.69M-0.2090Short Interest ↑News CoveragePositive NewsSABSSAB Biotherapeutics3.2579 of 5 stars$1.37-1.2%$11.40+729.7%-58.3%$12.76M$2.24M-0.37140Short Interest ↓Gap UpCRISCuris2.3111 of 5 stars$1.29flat$21.00+1,527.9%-88.7%$10.95M$10.91M-0.1760Analyst ForecastShort Interest ↑MTEMMolecular Templates0.6597 of 5 stars$0.00-50.0%N/AN/A$1,000.00$23.48M0.00260News CoverageAMGNAmgen4.4344 of 5 stars$295.30+0.5%$314.91+6.6%+4.0%$158.77B$33.42B39.1125,200Upcoming EarningsAnalyst ForecastAnalyst RevisionPositive NewsGILDGilead Sciences4.5819 of 5 stars$105.68-0.8%$105.12-0.5%+57.7%$131.59B$28.75B285.6217,000Earnings ReportDividend AnnouncementAnalyst ForecastAnalyst RevisionNews CoverageGap DownVRTXVertex Pharmaceuticals3.9255 of 5 stars$500.49+0.9%$512.41+2.4%+24.2%$128.52B$11.02B-227.506,100Analyst ForecastAnalyst RevisionPositive News Related Companies and Tools Related Companies Fortress Biotech Competitors Dominari Competitors Agenus Competitors Bolt Biotherapeutics Competitors SAB Biotherapeutics Competitors Curis Competitors Molecular Templates Competitors Amgen Competitors Gilead Sciences Competitors Vertex Pharmaceuticals Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:GTXI) was last updated on 4/27/2025 by MarketBeat.com Staff From Our PartnersElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored"I'm risking my reputation on this"I've discovered something so significant about the 2025 crypto market that I had to put everything else aside ...Crypto 101 Media | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | SponsoredTrump’s tariffs just split the AI market in twoTrump’s tariff just split the AI market – among others – in two. One group of AI companies—the ones relying...Traders Agency | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding GTx, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share GTX With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
